Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study

Jerome J. Federspiel, Carla A. Sueta, Anna M. Kucharska-Newton, Hadi Beyhaghi, Lei Zhou, Salim S. Virani, Jo E. Rodgers, Patricia P. Chang, Sally C. Stearns

Research output: Contribution to journalArticle

Abstract

Rationale, aims, and objectives: Despite proven benefits for reducing incidence of major cardiac events, antihypertensive drug therapy remains underutilized in the United States. This analysis assesses antihypertensive drug adherence, utilization predictors, and associations between adherence and outcomes (a composite of cardiovascular events, Medicare inpatient payments, and inpatient days). Methods: The sample consisted of Atherosclerosis Risk in Communities Study cohort participants reporting hypertension without prevalent cardiovascular disease during 2006 to 2007 annual follow-up calls. Atherosclerosis Risk in Communities records were linked to Medicare claims through 2012. Antihypertensive medication adherence was measured as more than 80% proportion days covered by using Medicare Part D claims. Standard and hierarchical regression models were used to evaluate adjusted associations between person characteristics and adherence and between adherence and outcomes. Results: Among 1826 hypertensive participants with Part D coverage, 31.5% had no antihypertensive class with more than 80% proportion days covered in the 3 months preceding the report of hypertension in 2006 to 2007. After adjustment for confounders, positive predictors of use included female gender and diabetes; negative predictors were African-American race and current smoking. Adjusted association between receiving no therapy and a composite endpoint of cardiovascular outcomes through 2012 was not statistically significant (hazard ratio: 0.93; 95% confidence interval: 0.72, 1.22) nor was the adjusted association with Medicare inpatient days or payments (incremental difference at 48 months in payments: $1217; 95% CI: −$2030, $4463). Conclusions: Despite having medical and prescription coverage, nearly a third of hypertensive participants were not adherent to antihypertensive drug therapy. Differences in clinical outcomes associated with nonadherence, though not statistically significant, were consistent with results from randomized trials. The approach provides a model framework for rigorous assessment of detailed data that are increasingly available through emerging sources.

LanguageEnglish (US)
Pages48-55
Number of pages8
JournalJournal of Evaluation in Clinical Practice
Volume24
Issue number1
DOIs
StatePublished - Feb 1 2018

Fingerprint

Independent Living
Medicare
Antihypertensive Agents
Atherosclerosis
Inpatients
Medicare Part D
Hypertension
Drug Utilization
Drug Therapy
Medication Adherence
African Americans
Prescriptions
Cohort Studies
Cardiovascular Diseases
Smoking
Confidence Intervals
Incidence

Keywords

  • Health care
  • health service research

ASJC Scopus subject areas

  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries : the Atherosclerosis Risk in Communities Study. / Federspiel, Jerome J.; Sueta, Carla A.; Kucharska-Newton, Anna M.; Beyhaghi, Hadi; Zhou, Lei; Virani, Salim S.; Rodgers, Jo E.; Chang, Patricia P.; Stearns, Sally C.

In: Journal of Evaluation in Clinical Practice, Vol. 24, No. 1, 01.02.2018, p. 48-55.

Research output: Contribution to journalArticle

Federspiel JJ, Sueta CA, Kucharska-Newton AM, Beyhaghi H, Zhou L, Virani SS et al. Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study. Journal of Evaluation in Clinical Practice. 2018 Feb 1;24(1):48-55. Available from, DOI: 10.1111/jep.12659
Federspiel, Jerome J. ; Sueta, Carla A. ; Kucharska-Newton, Anna M. ; Beyhaghi, Hadi ; Zhou, Lei ; Virani, Salim S. ; Rodgers, Jo E. ; Chang, Patricia P. ; Stearns, Sally C./ Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries : the Atherosclerosis Risk in Communities Study. In: Journal of Evaluation in Clinical Practice. 2018 ; Vol. 24, No. 1. pp. 48-55
@article{4f7cc154eaf94f0ebbdf4767b9ab9c24,
title = "Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study",
abstract = "Rationale, aims, and objectives: Despite proven benefits for reducing incidence of major cardiac events, antihypertensive drug therapy remains underutilized in the United States. This analysis assesses antihypertensive drug adherence, utilization predictors, and associations between adherence and outcomes (a composite of cardiovascular events, Medicare inpatient payments, and inpatient days). Methods: The sample consisted of Atherosclerosis Risk in Communities Study cohort participants reporting hypertension without prevalent cardiovascular disease during 2006 to 2007 annual follow-up calls. Atherosclerosis Risk in Communities records were linked to Medicare claims through 2012. Antihypertensive medication adherence was measured as more than 80{\%} proportion days covered by using Medicare Part D claims. Standard and hierarchical regression models were used to evaluate adjusted associations between person characteristics and adherence and between adherence and outcomes. Results: Among 1826 hypertensive participants with Part D coverage, 31.5{\%} had no antihypertensive class with more than 80{\%} proportion days covered in the 3 months preceding the report of hypertension in 2006 to 2007. After adjustment for confounders, positive predictors of use included female gender and diabetes; negative predictors were African-American race and current smoking. Adjusted association between receiving no therapy and a composite endpoint of cardiovascular outcomes through 2012 was not statistically significant (hazard ratio: 0.93; 95{\%} confidence interval: 0.72, 1.22) nor was the adjusted association with Medicare inpatient days or payments (incremental difference at 48 months in payments: $1217; 95{\%} CI: −$2030, $4463). Conclusions: Despite having medical and prescription coverage, nearly a third of hypertensive participants were not adherent to antihypertensive drug therapy. Differences in clinical outcomes associated with nonadherence, though not statistically significant, were consistent with results from randomized trials. The approach provides a model framework for rigorous assessment of detailed data that are increasingly available through emerging sources.",
keywords = "Health care, health service research",
author = "Federspiel, {Jerome J.} and Sueta, {Carla A.} and Kucharska-Newton, {Anna M.} and Hadi Beyhaghi and Lei Zhou and Virani, {Salim S.} and Rodgers, {Jo E.} and Chang, {Patricia P.} and Stearns, {Sally C.}",
year = "2018",
month = "2",
day = "1",
doi = "10.1111/jep.12659",
language = "English (US)",
volume = "24",
pages = "48--55",
journal = "Journal of Evaluation in Clinical Practice",
issn = "1356-1294",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries

T2 - Journal of Evaluation in Clinical Practice

AU - Federspiel,Jerome J.

AU - Sueta,Carla A.

AU - Kucharska-Newton,Anna M.

AU - Beyhaghi,Hadi

AU - Zhou,Lei

AU - Virani,Salim S.

AU - Rodgers,Jo E.

AU - Chang,Patricia P.

AU - Stearns,Sally C.

PY - 2018/2/1

Y1 - 2018/2/1

N2 - Rationale, aims, and objectives: Despite proven benefits for reducing incidence of major cardiac events, antihypertensive drug therapy remains underutilized in the United States. This analysis assesses antihypertensive drug adherence, utilization predictors, and associations between adherence and outcomes (a composite of cardiovascular events, Medicare inpatient payments, and inpatient days). Methods: The sample consisted of Atherosclerosis Risk in Communities Study cohort participants reporting hypertension without prevalent cardiovascular disease during 2006 to 2007 annual follow-up calls. Atherosclerosis Risk in Communities records were linked to Medicare claims through 2012. Antihypertensive medication adherence was measured as more than 80% proportion days covered by using Medicare Part D claims. Standard and hierarchical regression models were used to evaluate adjusted associations between person characteristics and adherence and between adherence and outcomes. Results: Among 1826 hypertensive participants with Part D coverage, 31.5% had no antihypertensive class with more than 80% proportion days covered in the 3 months preceding the report of hypertension in 2006 to 2007. After adjustment for confounders, positive predictors of use included female gender and diabetes; negative predictors were African-American race and current smoking. Adjusted association between receiving no therapy and a composite endpoint of cardiovascular outcomes through 2012 was not statistically significant (hazard ratio: 0.93; 95% confidence interval: 0.72, 1.22) nor was the adjusted association with Medicare inpatient days or payments (incremental difference at 48 months in payments: $1217; 95% CI: −$2030, $4463). Conclusions: Despite having medical and prescription coverage, nearly a third of hypertensive participants were not adherent to antihypertensive drug therapy. Differences in clinical outcomes associated with nonadherence, though not statistically significant, were consistent with results from randomized trials. The approach provides a model framework for rigorous assessment of detailed data that are increasingly available through emerging sources.

AB - Rationale, aims, and objectives: Despite proven benefits for reducing incidence of major cardiac events, antihypertensive drug therapy remains underutilized in the United States. This analysis assesses antihypertensive drug adherence, utilization predictors, and associations between adherence and outcomes (a composite of cardiovascular events, Medicare inpatient payments, and inpatient days). Methods: The sample consisted of Atherosclerosis Risk in Communities Study cohort participants reporting hypertension without prevalent cardiovascular disease during 2006 to 2007 annual follow-up calls. Atherosclerosis Risk in Communities records were linked to Medicare claims through 2012. Antihypertensive medication adherence was measured as more than 80% proportion days covered by using Medicare Part D claims. Standard and hierarchical regression models were used to evaluate adjusted associations between person characteristics and adherence and between adherence and outcomes. Results: Among 1826 hypertensive participants with Part D coverage, 31.5% had no antihypertensive class with more than 80% proportion days covered in the 3 months preceding the report of hypertension in 2006 to 2007. After adjustment for confounders, positive predictors of use included female gender and diabetes; negative predictors were African-American race and current smoking. Adjusted association between receiving no therapy and a composite endpoint of cardiovascular outcomes through 2012 was not statistically significant (hazard ratio: 0.93; 95% confidence interval: 0.72, 1.22) nor was the adjusted association with Medicare inpatient days or payments (incremental difference at 48 months in payments: $1217; 95% CI: −$2030, $4463). Conclusions: Despite having medical and prescription coverage, nearly a third of hypertensive participants were not adherent to antihypertensive drug therapy. Differences in clinical outcomes associated with nonadherence, though not statistically significant, were consistent with results from randomized trials. The approach provides a model framework for rigorous assessment of detailed data that are increasingly available through emerging sources.

KW - Health care

KW - health service research

UR - http://www.scopus.com/inward/record.url?scp=84996477468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996477468&partnerID=8YFLogxK

U2 - 10.1111/jep.12659

DO - 10.1111/jep.12659

M3 - Article

VL - 24

SP - 48

EP - 55

JO - Journal of Evaluation in Clinical Practice

JF - Journal of Evaluation in Clinical Practice

SN - 1356-1294

IS - 1

ER -